170 related articles for article (PubMed ID: 29164382)
1. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
Lee SJ; Zea R; Kim DH; Lubner MG; Deming DA; Pickhardt PJ
Eur Radiol; 2018 Apr; 28(4):1520-1528. PubMed ID: 29164382
[TBL] [Abstract][Full Text] [Related]
2. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes.
Lubner MG; Stabo N; Lubner SJ; del Rio AM; Song C; Halberg RB; Pickhardt PJ
Abdom Imaging; 2015 Oct; 40(7):2331-7. PubMed ID: 25968046
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Contrast-Enhanced CT and [
Wagner F; Hakami YA; Warnock G; Fischer G; Huellner MW; Veit-Haibach P
Mol Imaging Biol; 2017 Oct; 19(5):795-803. PubMed ID: 28224325
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma: CT texture analysis as a predictor of survival after surgical resection.
Brenet Defour L; Mulé S; Tenenhaus A; Piardi T; Sommacale D; Hoeffel C; Thiéfin G
Eur Radiol; 2019 Mar; 29(3):1231-1239. PubMed ID: 30159621
[TBL] [Abstract][Full Text] [Related]
5. CT texture analysis of liver metastases in PNETs versus NPNETs: Correlation with histopathological findings.
Martini I; Polici M; Zerunian M; Panzuto F; Rinzivillo M; Landolfi F; Magi L; Caruso D; Eid M; Annibale B; Laghi A; Iannicelli E
Eur J Radiol; 2020 Mar; 124():108812. PubMed ID: 31951893
[TBL] [Abstract][Full Text] [Related]
6. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.
Ng F; Ganeshan B; Kozarski R; Miles KA; Goh V
Radiology; 2013 Jan; 266(1):177-84. PubMed ID: 23151829
[TBL] [Abstract][Full Text] [Related]
7. CT texture analysis in colorectal liver metastases and the surrounding liver parenchyma and its potential as an imaging biomarker of disease aggressiveness, response and survival.
Beckers RCJ; Trebeschi S; Maas M; Schnerr RS; Sijmons JML; Beets GL; Houwers JB; Beets-Tan RGH; Lambregts DMJ
Eur J Radiol; 2018 May; 102():15-21. PubMed ID: 29685529
[TBL] [Abstract][Full Text] [Related]
8. Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
Simpson AL; Doussot A; Creasy JM; Adams LB; Allen PJ; DeMatteo RP; Gönen M; Kemeny NE; Kingham TP; Shia J; Jarnagin WR; Do RKG; D'Angelica MI
Ann Surg Oncol; 2017 Sep; 24(9):2482-2490. PubMed ID: 28560599
[TBL] [Abstract][Full Text] [Related]
9. Whole-volume vs. segmental CT texture analysis of the liver to assess metachronous colorectal liver metastases.
Beckers RCJ; Beets-Tan RGH; Schnerr RS; Maas M; da Costa Andrade LA; Beets GL; Dejong CH; Houwers JB; Lambregts DMJ
Abdom Radiol (NY); 2017 Nov; 42(11):2639-2645. PubMed ID: 28555265
[TBL] [Abstract][Full Text] [Related]
10. CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.
Froelich MF; Heinemann V; Sommer WH; Holch JW; Schoeppe F; Hesse N; Baumann AB; Kunz WG; Reiser MF; Ricke J; D'Anastasi M; Stintzing S; Modest DP; Kazmierczak PM; Hofmann FO
Eur Radiol; 2018 Dec; 28(12):5284-5292. PubMed ID: 29882070
[TBL] [Abstract][Full Text] [Related]
11. Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.
Durot C; Mulé S; Soyer P; Marchal A; Grange F; Hoeffel C
Eur Radiol; 2019 Jun; 29(6):3183-3191. PubMed ID: 30645669
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis.
Ahn SJ; Kim JH; Park SJ; Han JK
Eur J Radiol; 2016 Oct; 85(10):1867-1874. PubMed ID: 27666629
[TBL] [Abstract][Full Text] [Related]
13. Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival.
Ganeshan B; Miles KA; Young RC; Chatwin CR
Acad Radiol; 2007 Dec; 14(12):1520-30. PubMed ID: 18035281
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival.
Miles KA; Ganeshan B; Griffiths MR; Young RC; Chatwin CR
Radiology; 2009 Feb; 250(2):444-52. PubMed ID: 19164695
[TBL] [Abstract][Full Text] [Related]
15. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.
Ravanelli M; Agazzi GM; Tononcelli E; Roca E; Cabassa P; Baiocchi G; Berruti A; Maroldi R; Farina D
Radiol Med; 2019 Sep; 124(9):877-886. PubMed ID: 31172448
[TBL] [Abstract][Full Text] [Related]
16. Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
Mulé S; Thiefin G; Costentin C; Durot C; Rahmouni A; Luciani A; Hoeffel C
Radiology; 2018 Aug; 288(2):445-455. PubMed ID: 29584597
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival.
Oh J; Lee JM; Park J; Joo I; Yoon JH; Lee DH; Ganeshan B; Han JK
Korean J Radiol; 2019 Apr; 20(4):569-579. PubMed ID: 30887739
[TBL] [Abstract][Full Text] [Related]
18. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases.
Zhang H; Li W; Hu F; Sun Y; Hu T; Tong T
Abdom Radiol (NY); 2019 Jan; 44(1):65-71. PubMed ID: 29967982
[TBL] [Abstract][Full Text] [Related]
19. CT reconstruction algorithms affect histogram and texture analysis: evidence for liver parenchyma, focal solid liver lesions, and renal cysts.
Ahn SJ; Kim JH; Lee SM; Park SJ; Han JK
Eur Radiol; 2019 Aug; 29(8):4008-4015. PubMed ID: 30456584
[TBL] [Abstract][Full Text] [Related]
20. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
